NIVAS News Hub

Do you have news you would like to share on the NIVAS News Hub?

If you have an RSS feed you wish to share with up please contact us here.

Showing 1-12 of 1955 results.

IVTEAM

Catheter-related thrombosis in oncology patients with implanted ports

"For cancer patients who undergo ultrasound examinations for various reasons, the risk of CRT is relatively high. More attention should be paid to patients with breast cancer and with internal jugular vein implantation around 14 months after catheterization" Wu et al (2026)

IVTEAM

Artificial intelligence in hemodialysis

"This narrative review synthesizes recent advances in AI applications for hemodialysis, examining their potential, technical approaches, and practical effectiveness in addressing current management challenges" Ren et al (2026).

IVTEAM

Identification of risk factors for hospital-onset bacteremia – Full Text

"Most of the risk factors identified are well-recognized for Central Line-Associated Bloodstream Infection (CLABSI) and plausible contributors to HOB. Although not all HOB incidents are preventable, early identification of high-risk patients combined with risk-stratified targeted interventions can prevent cases and improve outcomes" Bludau et al (2026).

IVTEAM

Safety and efficacy of PICC-ports in oncology patients

"PICC-port implementation achieved excellent safety outcomes comparable to international benchmarks, supporting its use as an alternative to chest ports in resource-constrained settings" Watts-Pajaro et al (2026).

IVTEAM

Managing anxiety during preoperative peripheral IV insertion

"Current evidence for reducing anxiety during preoperative PIV insertion is limited and low in certainty. Lavender aromatherapy appears promising, but conclusions regarding its effectiveness should be considered preliminary" Majumdar et al (2026).

IVTEAM

Midline catheter use in the intensive care unit

"Midline catheters (MC) are 10-20 cm intravenous (IV) lines inserted in the peripheral veins of the upper arm and utilized for patients who require longer term IV access, making them advantageous in the intensive care unit (ICU)" King et al (2026).

IVTEAM

Intravenous iron administration and management of adverse events – Full Text

"Based on the available evidence, we provide practical recommendations for adverse events diagnosis, risk mitigation, patient counselling, and formulation selection to optimise the safe and effective use of i.v. iron for treatment and prevention of anaemia in routine clinical practice" Saal-Bauernschubert et al (2026).

IVTEAM

Central venous access device-associated complication costs – Full Text

"CVAD-associated complications remain a palpable cost in paediatric cancer care, with CLABSI carrying the highest cost burden. Therefore, investing in preventative care is encouraged to minimise the burden of complication costs to the healthcare system, and reduce the physical and emotional burden on patients and their families" Comber et al (2026).

NIVAS Partners

The NIVAS Board

UK Vessel Health & Preservation Video